Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group

被引：2

作者：

Lew-Derivry, Lucille ^{[1
]}

Marceau-Renaut, Alice ^{[2
]}

Fenwarth, Laurene ^{[2
,3
]}

Cuccuini, Wendy ^{[4
]}

Ballerini, Paola ^{[5
]}

Ferreboeuf, Maxime ^{[1
]}

Guilmatre, Audrey ^{[1
]}

Petit, Arnaud ^{[1
,6
]}

Gandemer, Virginie ^{[7
]}

Rialland, Fanny ^{[8
]}

Schneider, Pascale ^{[9
]}

Michel, Gerard ^{[10
]}

Bertrand, Yves ^{[11
]}

Baruchel, Andre ^{[12
]}

Preudhomme, Claude ^{[2
,3
]}

Leverger, Guy ^{[1
,6
]}

Lapillonne, Helene ^{[5
,6
]}

机构：

[1] Trousseau Hosp, AP HP, Pediat Hematol & Oncol Dept, F-75012 Paris, France

[2] CHU Lille, Lab Hematol, F-59000 Lille, France

[3] INSERM, UMR S 1172, F-59000 Lille, France

[4] St Louis Hosp, AP HP, Dept Cytogenet, F-75010 Paris, France

[5] Trousseau Hosp, AP HP, Lab Hematol, F-75012 Paris, France

[6] Sorbonne Univ, Ctr Rech St Antoine CRSA, INSERM, UMRS 938, F-75012 Paris, France

[7] Univ Hosp Rennes, Dept Pediat Hematol Oncol, F-35000 Rennes, France

[8] Univ Hosp Nantes, Dept Pediat Hematol Oncol, F-44000 Nantes, France

[9] Univ Hosp Charles Nicolle, Dept Pediat Hematol Oncol, F-76000 Rouen, France

[10] La Timone Univ Hosp, AP HM, Dept Pediat Hematol, F-13000 Marseille, France

[11] Hosp Civils Lyon, Inst Hematol & Oncol Pediat, F-69000 Lyon, France

[12] Robert Debre Univ Hosp, AP HP, Dept Pediat Hematol & Immunol, F-75019 Paris, France

来源：

LEUKEMIA | 2023年 / 37卷 / 08期

关键词：

RECOMMENDATIONS; AML;

D O I：

10.1038/s41375-023-01931-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1723 / 1726

页数：4

共 50 条

[21] Clinical Features and Prognostic Impact of RUNX1 and PTPN11 Mutations in Pediatric Acute Myeloid Leukemia-the Jccg Study, JPLSG AML-05-
Yamato, Genki
Shiba, Norio
Yoshida, Kenichi
Hara, Yusuke
Ohki, Kentaro
Okubo, Jun
Park, Myoung-Ja
Sotomatsu, Manabu
Taki, Tomohiko
Arakawa, Hirokazu
Kiyokawa, Nobutaka
Tomizawa, Daisuke
Adachi, Souichi
Taga, Takashi
Horibe, Keizo
Ogawa, Seishi
Hayashi, Yasuhide
BLOOD, 2017, 130
[22] Functional Characterization of Cooperating MGA Deletions in RUNX1::RUNX1T1 Acute Myeloid Leukemia
Thomas, Melvin Edward, III
BLOOD, 2022, 140 : 1275 - 1276
[23] Dysregulated MAPK signaling pathway in acute myeloid leukemia with RUNX1 mutations
He, Mingmin
Jia, Yongqin
Wang, Yan
Cai, Xiongwei
EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (08) : 769 - 779
[24] Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
Boissel, Nicolas
Nibourel, Olivier
Renneville, Aline
Gardin, Claude
Reman, Oumedaly
Contentin, Nathalie
Bordessoule, Dominique
Pautas, Cecile
de Revel, Thierry
Quesnel, Bruno
Huchette, Pascal
Philippe, Nathalie
Geffroy, Sandrine
Terre, Christine
Thomas, Xavier
Castaigne, Sylvie
Dombret, Herve
Preudhomme, Claude
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) : 3717 - 3723
[25] KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1
Srinivasan, Shyam
Dhamne, Chetan
Patkar, Nikhil
Chatterjee, Gaurav
Moulik, Nirmalya Roy
Chichra, Akanksha
Pallath, Aneeta
Tembhare, Prashant
Shetty, Dhanalaxmi
Subramanian, P. G.
Narula, Gaurav
Banavali, Shripad
PEDIATRIC BLOOD & CANCER, 2024, 71 (02)
[26] Adverse prognostic impact of KIT exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with RUNX1::RUNX1T1
Kato, Shota
Tsujimoto, Shin-Ichi
Matsubayashi, Jun
Iwamoto, Shotaro
Hiramatsu, Hidefumi
Okuno, Yusuke
Kamitori, Tatsuya
Ohki, Kentaro
Deguchi, Takao
Kiyokawa, Nobutaka
Kato, Motohiro
Takita, Junko
Tanaka, Shiro
Adachi, Souichi
Tomizawa, Daisuke
Shiba, Norio
HAEMATOLOGICA, 2025, 110 (01) : 251 - 256
[27] RUNX1 Mutations in Acute Myeloid Leukemia (AML): Correlation with Distinct Cytogenetic Subgroups and Clinical Outcome. Results of the AML Study Group (AMLSG)
Gaidzik, Verena I.
Schlenk, Richard F.
Wittke, Kerstin
Becker, Annegret
Zimmermann, Andreas
Schlegelberger, Brigitte
Ganser, Arnold
Spaeth, Daniela
Doehner, Hartmut
Doehner, Konstanze
BLOOD, 2008, 112 (11) : 59 - 59
[28] RUNX1 together with DAT mutations predicted poor outcome in acute myeloid leukemia
Xiao, Jinyan
Xie, Jundan
Zhou, Biqi
Liu, Yujie
Lu, Jing
Jiang, Airui
Yao, Hong
Qiu, Qiaocheng
Ding, Zixuan
Xue, Shengli
Tang, Xiaowen
Qiu, Huiying
Chen, Suning
Shen, Hongjie
Wu, Depei
Xu, Yang
LEUKEMIA & LYMPHOMA, 2023, 64 (05) : 951 - 961
[29] The role of RUNX1 DNA-Binding mutations in acute myeloid leukemia.
Cammenga, J
Putz, G
Niebuhr, B
Horn, S
Bergholz, U
Buchholz, F
Stocking, C
BLOOD, 2005, 106 (11) : 397A - 398A
[30] Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
H Matsuo
M Kajihara
D Tomizawa
T Watanabe
A M Saito
J Fujimoto
K Horibe
K Kodama
M Tokumasu
H Itoh
H Nakayama
A Kinoshita
T Taga
A Tawa
T Taki
S Tanaka
S Adachi
Blood Cancer Journal, 2014, 4 : e226 - e226

← 1 2 3 4 5 →